Diagnostics & Diseases Market Research Reports
Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction ... and Clarient. For the purpose of effective competitive analysis of the market, these companies have been analyzed in five major areas namely: ...
May, 2013 140 pages... , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Tuberculosis. Pulmonary Tuberculosis - Pipeline Review, Half Year is built using data and information sourced from ...
Apr, 2013 45 pages... , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Meningococcal Meningitis. Meningococcal Meningitis - Pipeline Review, Half Year is built using data and information sourced from ...
Apr, 2013 48 pages... reviews key players involved in the therapeutic development for Liver Diseases. Liver Diseases - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons to ...
Apr, 2013 331 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Gastric Motility Disorder pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating ...
Apr, 2013 42 pagesThis new 366-page report from Venture Planning Group contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument ...
Apr, 2013 366 pagesComplete report $5,900. DataPack (test volumes, sales forecasts, supplier shares) $2,350. Highlights Comprehensive 850-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and ...
Apr, 2013 850 pagesHighlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review ...
Apr, 2013 880 pagesHighlights Comprehensive 855-page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review ...
Apr, 2013 855 pagesHighlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
Apr, 2013 850 pagesHighlights Comprehensive 850-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
Apr, 2013 850 pagesHighlights Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
Apr, 2013 850 pagesHighlights Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
Apr, 2013 850 pages... opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features ...
Apr, 2013 970 pagesComplete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $3,400. Report Highlights Comprehensive 424-page analysis of the US hemostasis market. Major issues pertaining to the US hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and ...
Apr, 2013 424 pagesComplete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Report Highlights Comprehensive 409-page analysis of the UK hemostasis market. Major issues pertaining to the UK hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and ...
Apr, 2013 409 pagesComplete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Report Highlights Comprehensive 398-page analysis of the Spanish hemostasis market. Major issues pertaining to the Spanish hemostasis laboratory practice, as well as key economic, regulatory, demographic, social ...
Apr, 2013 398 pagesComplete report $6,500. DataPack (test volumes, sales forecasts, supplier shares) $2,450. Report Highlights Comprehensive 402-page analysis of the Japanese hemostasis market. Major issues pertaining to the Japanese hemostasis laboratory practice, as well as key economic, regulatory, demographic, social ...
Apr, 2013 402 pagesComplete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Report Highlights Comprehensive 402-page analysis of the Italian hemostasis market. Major issues pertaining to the Italian hemostasis laboratory practice, as well as key economic, regulatory, demographic, social ...
Apr, 2013 402 pagesComplete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Report Highlights Comprehensive 406-page analysis of the German hemostasis market, including: Major issues pertaining to the German hemostasis laboratory practice, as well as key economic, regulatory, demographic, ...
Apr, 2013 406 pages